• roche logo
  • Laboratorian women in the lab

    cobas® HPV Test

    Risk matters. Deliver 3 results in 1 test for accuracy that your clinical partners expect and that patients deserve      

 

 

News

 

Roche Issues Press Release Announcing ACOG Support of HPV Primary Screening (Feb 2016)

Read article >

 

ACOG Practice Bulletin #157 on Support for HPV Primary Screening (Jan 2016)

Read article ›

 

US medical societies new guidance for cervical cancer screening

Read article ›

 

Roche press release on new guidance for cervical cancer screening

Read article ›

 

End-of-study results from ATHENA newly published in Gynecologic Oncology

Read article ›

 

News Archive:

Webinar: An Update on Cervical Cancer Screening Algorithms: Should HPV or Cytology be the Primary Test?

Watch webinar ›

 

Dr. Mark Stoler on clinical data that sparks new directions in cervical cancer

Read article ›

 

Health Canada Approves Roche’s HPV Test for First-Line Primary Screening of Cervical Cancer and Roche Launches New Cytology Test to Provide the Most Comprehensive Portfolio for Cervical Cancer Screening

Read article ›

 

FDA Advisory Committee Unanimously Recommends Roche's HPV Test as Primary Screening Tool for Detection of Women at High Risk for Cervical Cancer

Read article ›

 

HPV and Pap: Shifting Roles in Cervical Cancer Screening

Read article ›

 

FDA approves new streamlined workflow option for Roche's cobas® HPV Test

Read article ›

 

Assessing the Impact of New Cervical Cancer Screening Guidelines

Read article ›

 

New Professional Guidelines Recognize Benefit of Genotyping HPV 16 and 18 for Cervical Cancer Prevention by Assessing Individual Patient Risk

Read article ›

 

ACS: New Screening Guidelines for Cervical Cancer

Read article ›

 

ACOG: Practice Bulletin 131 Screening for Cervical Cancer

Read article ›

 

Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer

Read article ›

 

Institute of Medicine: Clinical Preventive Services for Women: Closing the Gaps 

Read article ›

 

Preventive Services Covered Under the Affordable Care Act

Read article ›

 

FDA Approves Roche's HPV Test for Identifying Women at Highest Risk for Cervical Cancer

Read article ›

 

Principal Publications

Primary cervical cancer screening with human papillomavirus: End-of-study results from the ATHENA study using HPV as the first-line screening test

      Wright TC Jr, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Gynecol Oncol (2015).

Read research ›

 

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of High-risk HPV Positive Cytology Negative Women

      Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens CM, Wright TL. Am J Clin Pathol 2011; 136:578-586.

Read research ›

 

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology. Results From the ATHENA HPV Study

      Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL. Am J Clin Pathol 2011; 135:468-475.

Read research ›

 

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Cytology. Results from the ATHENA HPV Study

      Stoler, MH, Wright TC Jr, Sharma A, Zhang G, Apple R, Wright TL, Behrens CM. Am J Clin Pathol 2012; 137:295-303.

Read research ›

 

The ATHENA human papillomavirus study: design, methods, and baseline results

      Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. Am J Obstet Gynecol 2011; in press. 

Read research ›

STAY INFORMED

Sign up to receive updates on the cobas® 4800 HPV Test and other related news.

 Sign Up
  • Acronyms: